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Background
It has been suggested that disturbance of the NO-cGMP
pathway lead to impaired relaxation of the urethral out-
flow region, increased bladder afferent activity and over-
active bladder, but the precise role of NO in regulating the
detrusor smooth muscle (DSM) functions remains to be
determined.
Purpose
Our present work aimed to examine the functional and
biochemical alterations of rat DSM after chronic NO
blockade.
Methods
Male Wistar rats were treated orally with L-NAME (20 mg/
rat/day) for 30 days. Age-matched control animals
received tap water alone. Concentration-response curves
to full agonist carbachol (CCh, 1 nM-30 μM) in the DSM
were obtained. The values of potency (pEC50) and maxi-
mal responses (Emax) were calculated. The IP3 accumula-
tion and the nitric oxide synthase (NOS) activity, as well
as morphometric analyses were evaluated in the urinary
bladder of control and L-NAME-treated rats.
Results
L-NAME-treated rats presented a marked arterial hyper-
tension (ctrl:124 ± 2 vs treated: 198 ± 1 mmHg) and a
reduction of 86% in the total NOS activity in the isolated
rat bladder. Four-weeks treatment with L-NAME increased
by 5-fold the CCh potency (6.09 ± 0.02 vs 6.82 ± 0.06),
without modifying the Emax (ctl: 3.50 ± 0.10 vs treated:
3.40 ± 0.07) (Figure 1A). Incubation of urinary bladder
with CCh (10-9–10-3 M) concentration-dependently
increased the total [3H]-inositol phosphates in rat urinary
bladder that was markedly higher in L-NAME-treated rats
compared with control animals (Figure 1B). The measure-
ment of the thickness of rat isolated bladder revealed that
L-NAME treatment for 30 days caused no alterations in
the thickness of submucosa and muscular layers of the
DSM when compared with control animals. However, in
the trigone smooth muscle (TSM), L-NAME treatment sig-
nificantly increased the thickness of the muscular layer
without changing the thickness of the sub-mucosa layer
(Table 1).
Conclusion
Our findings show that long-term NO inhibition signifi-
cantly increases the sensitivity of DSM for the muscarinic
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agonist carbachol via accumulation of IP3, suggesting that
NO exerts a modulatory effect on the contractility medi-
ated by muscarinic receptors.
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(A) Concentration-response curve to carbachol in rat DSM from control and L-NAME-treated rats in 30 days (n = 6–8, p < 0.05)Figure 1
(A) Concentration-response curve to carbachol in rat DSM from control and L-NAME-treated rats in 30 days (n = 6–8, p < 
0.05). (B) Effects of carbachol on total [3H]-inositol phosphate accumulation in both control and L-NAME-treated group in 30 
days (n = 3–6, P < 0.05).
Table 1: Morphometric analyses in isolated rat detrusor and trigone smooth muscle in control and L-NAME-treated groups in 30 days. 
*p < 0.05.
Detrusor (μm) Trigone (μm)
Layers Control L-NAME Control L-NAME
Total 1194 ± 73.09 1098 ± 67.72 705 ± 19.56 861 ± 21.85*
Muscular 610 ± 37.18 658 ± 32.24 526 ± 24.29 677 ± 30.49*
Serosal 547 ± 66.36 494 ± 56.15 176 ± 12.47 183 ± 17.11Page 2 of 2
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